Back to Trades
Breedlove Robert Charles
InsiderCIK 0002066645
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Breedlove Robert Charles has filed 7 SEC reports (2025–2026), all concentrated in Phathom Pharmaceuticals, Inc. (PHAT), totaling $72.7K in disclosed volume. Weighing $0 bought versus $19.7K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Sep 8 | PHAT Phathom Pharmaceuticals, Inc. | Breedlove Robert Charles | Insider | Tax withheld | $4.2K |
| Jul 16 | PHAT Phathom Pharmaceuticals, Inc. | Breedlove Robert Charles | Insider | Tax withheld | $17.2K |
| Mar 3 | PHAT Phathom Pharmaceuticals, Inc. | Breedlove Robert Charles | Insider | Grant | $17.3K |
| Jan 23 | PHAT Phathom Pharmaceuticals, Inc. | Breedlove Robert Charles | Insider | Tax withheld | $10.6K |
| Dec 19 | PHAT Phathom Pharmaceuticals, Inc. | Breedlove Robert Charles | Insider | Tax withheld | $3.7K |
| Sep 9 | PHAT Phathom Pharmaceuticals, Inc. | Breedlove Robert Charles | Insider | Sell | $5.6K |
| Jul 18 | PHAT Phathom Pharmaceuticals, Inc. | Breedlove Robert Charles | Insider | Sell | $14.2K |
7 filings